 |
PDBsum entry 1gfy
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.1.3.48
- protein-tyrosine-phosphatase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
O-phospho-L-tyrosyl-[protein] + H2O = L-tyrosyl-[protein] + phosphate
|
 |
 |
 |
 |
 |
O-phospho-L-tyrosyl-[protein]
|
+
|
H2O
|
=
|
L-tyrosyl-[protein]
|
+
|
phosphate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
J Biol Chem
275:18201-18209
(2000)
|
|
PubMed id:
|
|
|
|
|
| |
|
Residue 259 is a key determinant of substrate specificity of protein-tyrosine phosphatases 1B and alpha.
|
|
G.H.Peters,
L.F.Iversen,
S.Branner,
H.S.Andersen,
S.B.Mortensen,
O.H.Olsen,
K.B.Moller,
N.P.Moller.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The aim of this study was to define the structural elements that determine the
differences in substrate recognition capacity of two protein-tyrosine
phosphatases (PTPs), PTP1B and PTPalpha, both suggested to be negative
regulators of insulin signaling. Since the Ac-DADE(pY)L-NH(2) peptide is well
recognized by PTP1B, but less efficiently by PTPalpha, it was chosen as a tool
for these analyses. Calpha regiovariation analyses and primary sequence
alignments indicate that residues 47, 48, 258, and 259 (PTP1B numbering) define
a selectivity-determining region. By analyzing a set of DADE(pY)L analogs with a
series of PTP mutants in which these four residues were exchanged between PTP1B
and PTPalpha, either in combination or alone, we here demonstrate that the key
selectivity-determining residue is 259. In PTPalpha, this residue is a glutamine
causing steric hindrance and in PTP1B a glycine allowing broad substrate
recognition. Significantly, replacing Gln(259) with a glycine almost turns
PTPalpha into a PTP1B-like enzyme. By using a novel set of PTP inhibitors and
x-ray crystallography, we further provide evidence that Gln(259) in PTPalpha
plays a dual role leading to restricted substrate recognition (directly via
steric hindrance) and reduced catalytic activity (indirectly via Gln(262)). Both
effects may indicate that PTPalpha regulates highly selective signal
transduction processes.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Fig. 1. Chemical structures of compounds 1-4.
|
 |
Figure 7.
Fig. 7. Schematic presentation of the catalytic reaction
showing the proposed effects of the side chain Gln259.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2000,
275,
18201-18209)
copyright 2000.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
Y.Huang,
and
A.Dömling
(2011).
The Gewald multicomponent reaction.
|
| |
Mol Divers,
15,
3.
|
 |
|
|
|
|
 |
A.J.Barr,
E.Ugochukwu,
W.H.Lee,
O.N.King,
P.Filippakopoulos,
I.Alfano,
P.Savitsky,
N.A.Burgess-Brown,
S.Müller,
and
S.Knapp
(2009).
Large-scale structural analysis of the classical human protein tyrosine phosphatome.
|
| |
Cell,
136,
352-363.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
G.H.Peters
(2009).
The effect of Asp54 phosphorylation on the energetics and dynamics in the response regulator protein Spo0F studied by molecular dynamics.
|
| |
Proteins,
75,
648-658.
|
 |
|
|
|
|
 |
A.J.Barr,
J.E.Debreczeni,
J.Eswaran,
and
S.Knapp
(2006).
Crystal structure of human protein tyrosine phosphatase 14 (PTPN14) at 1.65-A resolution.
|
| |
Proteins,
63,
1132-1136.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.Eswaran,
J.E.Debreczeni,
E.Longman,
A.J.Barr,
and
S.Knapp
(2006).
The crystal structure of human receptor protein tyrosine phosphatase kappa phosphatase domain 1.
|
| |
Protein Sci,
15,
1500-1505.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
W.H.Lee,
A.Raas-Rotschild,
M.A.Miteva,
G.Bolasco,
A.Rein,
D.Gillis,
D.Vidaud,
M.Vidaud,
B.O.Villoutreix,
and
B.Parfait
(2005).
Noonan syndrome type I with PTPN11 3 bp deletion: structure-function implications.
|
| |
Proteins,
58,
7.
|
 |
|
|
|
|
 |
T.O.Johnson,
J.Ermolieff,
and
M.R.Jirousek
(2002).
Protein tyrosine phosphatase 1B inhibitors for diabetes.
|
| |
Nat Rev Drug Discov,
1,
696-709.
|
 |
|
|
|
|
 |
J.N.Andersen,
O.H.Mortensen,
G.H.Peters,
P.G.Drake,
L.F.Iversen,
O.H.Olsen,
P.G.Jansen,
H.S.Andersen,
N.K.Tonks,
and
N.P.Møller
(2001).
Structural and evolutionary relationships among protein tyrosine phosphatase domains.
|
| |
Mol Cell Biol,
21,
7117-7136.
|
 |
|
|
|
|
 |
A.Salmeen,
J.N.Andersen,
M.P.Myers,
N.K.Tonks,
and
D.Barford
(2000).
Molecular basis for the dephosphorylation of the activation segment of the insulin receptor by protein tyrosine phosphatase 1B.
|
| |
Mol Cell,
6,
1401-1412.
|
 |
|
PDB codes:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |